These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 37468213)
1. Urine Drug Testing Among Patients Prescribed Long-Term Opioid Therapy: Patient and Clinician Factors. Agnoli AL; Howe R; Magnan E; Jerant A; Colby D; Franks P J Am Board Fam Med; 2023 Aug; 36(4):537-541. PubMed ID: 37468213 [TBL] [Abstract][Full Text] [Related]
2. Predictors of urine drug testing for patients with chronic pain: Results from a national cohort of U.S. veterans. Morasco BJ; Peters D; Krebs EE; Kovas AE; Hart K; Dobscha SK Subst Abus; 2016; 37(1):82-7. PubMed ID: 26516794 [TBL] [Abstract][Full Text] [Related]
3. Clinician Response to Aberrant Urine Drug Test Results of Patients Prescribed Opioid Therapy for Chronic Pain. Morasco BJ; Krebs EE; Adams MH; Hyde S; Zamudio J; Dobscha SK Clin J Pain; 2019 Jan; 35(1):1-6. PubMed ID: 30222612 [TBL] [Abstract][Full Text] [Related]
4. Stimulant use and opioid-related harm in patients on long-term opioids for chronic pain. Appa A; McMahan VM; Long K; Shade SB; Coffin PO Drug Alcohol Depend; 2024 Mar; 256():111065. PubMed ID: 38245963 [TBL] [Abstract][Full Text] [Related]
5. Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain? Larochelle MR; Cruz R; Kosakowski S; Gourlay DL; Alford DP; Xuan Z; Krebs EE; Yan S; Lasser KE; Samet JH; Liebschutz JM J Gen Intern Med; 2022 Aug; 37(10):2365-2372. PubMed ID: 34405344 [TBL] [Abstract][Full Text] [Related]
6. Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified. Wyse JJ; Morasco BJ; Dobscha SK; Demidenko MI; Meath THA; Lovejoy TI J Opioid Manag; 2018; 14(4):295-303. PubMed ID: 30234926 [TBL] [Abstract][Full Text] [Related]
7. Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test? Chakravarthy K; Goel A; Jeha GM; Kaye AD; Christo PJ Curr Pain Headache Rep; 2021 Feb; 25(2):12. PubMed ID: 33598816 [TBL] [Abstract][Full Text] [Related]
8. Urine drug testing in the context of opioid analgesic prescribing for chronic pain: a content analysis of U.S. state laws in 2022. Andraka-Christou B; McAvoy E; Gordon AJ; Ohama M; Brach M; Taylor EA; Vaiana M; Saloner B; Stein BD Pain Med; 2023 Dec; 24(12):1306-1317. PubMed ID: 37551941 [TBL] [Abstract][Full Text] [Related]
9. Predictors of higher-risk chronic opioid prescriptions in an academic primary care setting. Bauer SR; Hitchner L; Harrison H; Gerstenberger J; Steiger S Subst Abus; 2016; 37(1):110-7. PubMed ID: 26848633 [TBL] [Abstract][Full Text] [Related]
10. Compliance with Opioid Therapy: Distinguishing Clinical Characteristics and Demographics Among Patients with Cancer Pain. Koyyalagunta D; Bruera E; Engle MP; Driver L; Dong W; Demaree C; Novy DM Pain Med; 2018 Jul; 19(7):1469-1477. PubMed ID: 29016951 [TBL] [Abstract][Full Text] [Related]
11. Systematic urine drug testing for detecting and managing opioid misuse among chronic noncancer pain patients in primary care-The HARMS Program: A retrospective chart review of 77 patients. Shahi N; Patchett-Marble R J Opioid Manag; 2020; 16(4):277-282. PubMed ID: 32885835 [TBL] [Abstract][Full Text] [Related]
16. Urine drug testing in chronic pain. Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368 [TBL] [Abstract][Full Text] [Related]
17. Random urine drug testing among patients receiving opioid therapy for cancer pain. Arthur JA; Tang M; Lu Z; Hui D; Nguyen K; Rodriguez EM; Edwards T; Yennurajalingam S; Dalal S; Dev R; Reddy A; Tanco K; Haider A; Liu DD; Bruera E Cancer; 2021 Mar; 127(6):968-975. PubMed ID: 33231885 [TBL] [Abstract][Full Text] [Related]
18. Substance Use Disorder Treatment Following Clinician-Initiated Discontinuation of Long-Term Opioid Therapy Resulting from an Aberrant Urine Drug Test. Nugent SM; Dobscha SK; Morasco BJ; Demidenko MI; Meath THA; Frank JW; Lovejoy TI J Gen Intern Med; 2017 Oct; 32(10):1076-1082. PubMed ID: 28600754 [TBL] [Abstract][Full Text] [Related]
19. Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant results. Turner JA; Saunders K; Shortreed SM; LeResche L; Riddell K; Rapp SE; Von Korff M J Gen Intern Med; 2014 Dec; 29(12):1663-71. PubMed ID: 25217208 [TBL] [Abstract][Full Text] [Related]
20. Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patients. Gaither JR; Gordon K; Crystal S; Edelman EJ; Kerns RD; Justice AC; Fiellin DA; Becker WC Drug Alcohol Depend; 2018 Nov; 192():371-376. PubMed ID: 30122319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]